Eisler Capital (Uk) Ltd. Pfizer Inc Put Options Transaction History

Eisler Capital (Uk) Ltd.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $18.5 Million - $21 Million	668,841 Added 41.38%	2,285,175 $66.1 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $12.5 Million - $14.6 Million	494,762 Added 44.11%	1,616,334 $45.2 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $8.3 Million - $9.53 Million	320,543 Added 40.02%	1,121,572 $31.1 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $13.5 Million - $17.6 Million	517,733 Added 182.75%	801,029 $23.1 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $9.09 Million - $10.6 Million	283,296 New	283,296 $9.4 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.